Literature DB >> 1352199

Effects of oleic acid and endogenous bile on duodenal secretion of somatostatin in man.

O Olsen1, J J Holst, O B Schaffalitzky De Muckadell.   

Abstract

We studied the effects of intraduodenal oleic acid on the release of somatostatin to plasma and the correlation between endogenous bile output and plasma somatostatin. In five normal persons infusion of 0, 5, 10, 20, and 40 mM oleic acid dose-dependently increased the levels of somatostatin during as well as after gallbladder emptying. The difference between somatostatin concentration during and after gallbladder emptying was not significant. The amylase secretion also was significantly correlated to the dose of fat, whereas the output of bile salts was the same for all fat doses used. Our observations indicate that intraduodenal oleic acid--and not bile salts--releases somatostatin from the gut.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1352199     DOI: 10.1007/bf01300282

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  18 in total

1.  Mechanism of oleic acid-induced inhibition on gastric acid secretion in rats.

Authors:  J C Rhee; T M Chang; K Y Lee; Y H Jo; W Y Chey
Journal:  Am J Physiol       Date:  1991-04

2.  Quantitative determination of bile acids and their conjugates using thin-layer chromatography and a purified 3alpha-hydroxysteroid dehydrogenase.

Authors:  O Fausa; B A Skålhegg
Journal:  Scand J Gastroenterol       Date:  1974       Impact factor: 2.423

3.  Is somatostatin a humoral regulator of the endocrine pancreas and gastric acid secretion in man?

Authors:  F B Loud; J J Holst; E Egense; B Petersen; J Christiansen
Journal:  Gut       Date:  1985-05       Impact factor: 23.059

4.  On the accuracy of radioimmunological determination of somatostatin in plasma.

Authors:  L Hilsted; J J Holst
Journal:  Regul Pept       Date:  1982-06

5.  Response of circulating somatostatin, insulin, gastrin and GIP, to intraduodenal infusion of nutrients in normal man.

Authors:  M R Lucey; P D Fairclough; J A Wass; P Kwasowski; S Medbak; J Webb; L H Rees
Journal:  Clin Endocrinol (Oxf)       Date:  1984-09       Impact factor: 3.478

6.  Circulating somatostatin. Physiological regulator of pancreatic function?

Authors:  K Gyr; C Beglinger; E Köhler; U Trautzl; U Keller; S R Bloom
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

7.  Comparison of effects of ingested medium- and long-chain triglyceride on gallbladder volume and release of cholecystokinin and other gut peptides.

Authors:  P E Isaacs; S Ladas; I C Forgacs; R H Dowling; S V Ellam; T E Adrian; S R Bloom
Journal:  Dig Dis Sci       Date:  1987-05       Impact factor: 3.199

8.  Somatostatin 1-28 circulates in human plasma.

Authors:  F G Baldissera; M A Munoz-Perez; J J Holst
Journal:  Regul Pept       Date:  1983-04

9.  SCE Nordic alpha-amylase method selection and calibration study. A report by the Committee of Enzymes of the Scandinavian Society for Clinical Chemistry (SCE).

Authors:  W Gerhardt; J Waldenstrøm; M Hörder; E Magid; J H Strømme; L Theodorsen; M Härkönen; A Icén
Journal:  Scand J Clin Lab Invest       Date:  1985-09       Impact factor: 1.713

10.  Effect of ingested carbohydrate, fat, and protein on the release of somatostatin-28 in humans.

Authors:  J W Ensinck; R E Vogel; E C Laschansky; B H Francis
Journal:  Gastroenterology       Date:  1990-03       Impact factor: 22.682

View more
  1 in total

Review 1.  Adaptation of the exocrine pancreas to dietary fats.

Authors:  M D Yago; E Martínez-Victoria; R J Díaz; M A Martínez; J Singh; M Mañas
Journal:  J Physiol Biochem       Date:  2000-09       Impact factor: 4.158

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.